Mercer Global Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,410
| Closed | -$1.44M | – | 2132 |
|
|
2023
Q3 | $1.44M | Buy |
12,410
+895
| +8% | +$104K | 0.01% | 805 |
|
|
2023
Q2 | $1.18M | Buy |
11,515
+7,613
| +195% | +$783K | ﹤0.01% | 890 |
|
|
2023
Q1 | $426K | Buy |
3,902
+1,397
| +56% | +$153K | ﹤0.01% | 1291 |
|
|
2022
Q4 | $285K | Buy |
+2,505
| New | +$285K | ﹤0.01% | 1528 |
|
|
2022
Q3 | – | Sell |
-2,565
| Closed | -$205K | – | 1948 |
|
|
2022
Q2 | $205K | Sell |
2,565
-543
| -17% | -$43.4K | ﹤0.01% | 1627 |
|
|
2022
Q1 | $327K | Buy |
+3,108
| New | +$327K | ﹤0.01% | 1467 |
|
|
2021
Q4 | – | Sell |
-2,204
| Closed | -$241K | – | 1877 |
|
|
2021
Q3 | $241K | Sell |
2,204
-276
| -11% | -$30.2K | ﹤0.01% | 1520 |
|
|
2021
Q2 | $232K | Sell |
2,480
-2,806
| -53% | -$262K | ﹤0.01% | 1498 |
|
|
2021
Q1 | $487K | Buy |
5,286
+1,539
| +41% | +$142K | ﹤0.01% | 1089 |
|
|
2020
Q4 | $274K | Buy |
+3,747
| New | +$274K | ﹤0.01% | 1102 |
|